Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Live-attenuated Shigella vaccines.

Malabi M Venkatesan1, Ryan T Ranallo

  • 1Division of Bacterial and Rickettsial Diseases, Walter Reed Army Institute of Research, 503 Robert Forney Drive, Room 3s12, Silver Spring, MD 20910, USA. malabi.venkatesan@na.amedd.army.mil

Expert Review of Vaccines
|December 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial.

The Lancet. Infectious diseases·2026
Same author

National Institutes of Health-Wide Workshop: Impact of Diet on Mucosal Immunity and Immune-Mediated Inflammatory Diseases of the Gastrointestinal Tract.

Gastro hep advances·2025
Same author

Neuroimmune interactions in health and disease.

Nature immunology·2025
Same author

A rhesus macaque intragastric challenge model for evaluating the safety, immunogenicity, and efficacy of live-attenuated <i>Shigella dysenteriae</i> 1 vaccine candidates.

Frontiers in microbiology·2024
Same author

B memory cell responses to LPS, IVP and IpaB antigen after oral vaccination with Shigella sonnei vaccine candidates WRSs2 and WRSs3.

PloS one·2024
Same author

Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding.

PloS one·2021

Live-attenuated Shigella vaccines show promise for oral administration, inducing significant immune responses. Research reviews volunteer trials, comparing vaccine strains and immune correlates for protection against Shigella infection.

Area of Science:

  • Microbiology
  • Immunology
  • Vaccinology

Background:

  • Live-attenuated Shigella vaccines, engineered with specific genetic mutations, are being developed for oral administration.
  • These vaccines aim to elicit robust immune responses against Shigella infections, a significant public health concern.

Purpose of the Study:

  • To review and synthesize data from volunteer trials of live-attenuated Shigella vaccines.
  • To describe vaccine strain characteristics, immune responses, and dosing regimens.
  • To compare vaccine efficacy with challenge trial data and discuss correlates of protection.

Main Methods:

  • Review of published and unpublished data from volunteer trials involving live-attenuated Shigella vaccines.
  • Analysis of immune responses, including antibody-secreting cells, serum antibodies, and fecal immunoglobulin A (IgA).

Related Experiment Videos

  • Comparison of immune responses to specific bacterial antigens (lipopolysaccharide, invasion plasmid antigens) and challenge trial outcomes.

    • Main Results:

    • Live-attenuated Shigella vaccines induce measurable immune responses in volunteers, including antibody production.
    • Different vaccine strains and dosing regimens elicit varying levels of immune responses.
    • While correlates of protection are not definitively established, a consensus on potential protective immune responses is emerging.

    Conclusions:

    • Live-attenuated Shigella vaccines represent a promising strategy for preventing Shigella infections.
    • Further research is needed to fully elucidate correlates of protection and optimize vaccine efficacy.
    • Future directions include refining vaccine strains and understanding optimal immunization strategies.